BAC
Waltham
About BAC
BAC BV provides affinity purification products and services for the biopharmaceutical market. Their CaptureSelect products are used for drug discovery upto manufacturing of biopharmaceuticals and are based on a proprietary platform technology, integrating affinity ligand discovery, manufacturing and immobilization of single domain antibodies derived from Camelids.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 10,001+
- Total funding: $2.2M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2008)
- Website: bacbv.com
- Phone: +49 6103 4080
Industries & Categories
Biopharma, Life Science, Market Research
Canonical: https://fsome.com/organization/bac-2066411 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.